Location History:
- Salisbury, GB (2008)
- Auckland, NZ (2012 - 2013)
Company Filing History:
4 out of 4 
4 out of 38 
Years Active: 2008-2013
Title: Michael Herbert: Innovator in Protective Antigen Research
Introduction
Michael Herbert is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of biotechnology, particularly in the development of protective antigens. With a total of 4 patents to his name, Herbert's work has had a substantial impact on vaccine research and development.
Latest Patents
Among his latest patents is the "Preparation of Protective Antigen," which involves a polynucleotide sequence encoding recombinant Protective Antigen (rPA). This invention includes expression vectors and host cells that utilize the polynucleotide sequence, along with methods for producing rPA. This innovative approach is crucial for advancing vaccine technologies.
Career Highlights
Throughout his career, Michael Herbert has worked with prominent organizations such as Dynport Vaccine Company LLC and the Health Protection Agency. His experience in these companies has allowed him to apply his expertise in developing effective vaccine solutions.
Collaborations
Michael has collaborated with esteemed colleagues, including Ian McEntee and Philip Vincent. These partnerships have further enriched his research and contributed to the success of his projects.
Conclusion
Michael Herbert's contributions to the field of protective antigens exemplify his dedication to advancing vaccine research. His innovative patents and collaborations highlight his role as a key figure in biotechnology.